Serum Interleukin-26 Is a New Biomarker for Disease Activity Assessment in Systemic Lupus Erythematosus

OBJECTIVE: Interleukin-26 (IL-26) has a unique ability to activate innate immune cells due to its binding to circulating double-stranded DNA. High levels of IL-26 have been reported in patients with chronic inflammation. We aimed to investigate IL-26 levels in patients with systemic lupus erythemato...

Descripción completa

Detalles Bibliográficos
Autores principales: Brilland, Benoit, Bach-Bunner, Maxime, Gomes, Christopher Nunes, Larochette, Vincent, Foucher, Etienne, Plaisance, Marc, Saulnier, Patrick, Costedoat-Chalumeau, Nathalie, Ghillani, Pascale, Belizna, Cristina, Delneste, Yves, Augusto, Jean-François, Jeannin, Pascale
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160525/
https://www.ncbi.nlm.nih.gov/pubmed/34054830
http://dx.doi.org/10.3389/fimmu.2021.663192

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160525/
https://www.ncbi.nlm.nih.gov/pubmed/34054830
http://dx.doi.org/10.3389/fimmu.2021.663192

Ejemplares similares